Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock

BACKGROUND: Despite advances in surgical techniques and aggressive therapy of post-infarction ventricular septal defect (VSD) with cardiogenic shock, the overall morbidity and mortality is frustratingly high. The Impella 5.5 SmartAssist (Abiomed, Danvers, MA) is a surgically implanted temporary devi...

Descripción completa

Detalles Bibliográficos
Autores principales: Madjarov, Jeko M., Katz, Michael G., Madzharov, Svetozar, Fazal, Shahood, Robicsek, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130376/
https://www.ncbi.nlm.nih.gov/pubmed/34001192
http://dx.doi.org/10.1186/s13019-021-01513-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130376/
https://www.ncbi.nlm.nih.gov/pubmed/34001192
http://dx.doi.org/10.1186/s13019-021-01513-y

Ejemplares similares